# Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Study · id `cardio:ct-nct04807400` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04807400](<https://clinicaltrials.gov/study/NCT04807400>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04807400

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 892 participants.

## Technical summary

Registry record NCT04807400. Randomized; no masking; primary purpose health services research. Start 2021-07-07 (actual); primary completion 2023-01-13 (actual). Results posted on 2024-03-25.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Phase 3
- Enrolled: 892 participants (enrolled count; ClinicalTrials.gov record NCT04807400, source copy `cardio:ctgov-nct04807400-2024-10-09`, retrieved 2026-10-31)
- Started: 2021-07-07 (actual) (ClinicalTrials.gov record NCT04807400, source copy `cardio:ctgov-nct04807400-2024-10-09`, retrieved 2026-10-31)
- Primary completion: 2023-01-13 (actual) (ClinicalTrials.gov record NCT04807400, source copy `cardio:ctgov-nct04807400-2024-10-09`, retrieved 2026-10-31)
- Completion: 2023-01-13 (actual) (ClinicalTrials.gov record NCT04807400, source copy `cardio:ctgov-nct04807400-2024-10-09`, retrieved 2026-10-31)
- Results first posted: 2024-03-25 (ClinicalTrials.gov record NCT04807400, source copy `cardio:ctgov-nct04807400-2024-10-09`, retrieved 2026-10-31)
- Countries: United Kingdom (ClinicalTrials.gov record NCT04807400, source copy `cardio:ctgov-nct04807400-2024-10-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04807400-2024-10-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support
- Acronym: SPIRIT
- Condition: Atherosclerotic Cardiovascular Disease
- Condition: Atherosclerotic Cardiovascular Disease Risk Equivelents
- Condition: Elevated Low Density Lipoprotein Cholesterol
- Intervention (Drug): Inclisiran
- Intervention (Behavioral): Behavioural Support
- Intervention (Drug): Background lipid lowering therapy
- Lead sponsor: Novartis Pharmaceuticals
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry intervention name matches this record: Inclisiran (`cardio:inclisiran`)
- Registry lists this organization as the lead sponsor: Novartis (`cardio:novartis`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Development and application of a qualitative rapid analysis framework in a hybrid trial within primary care (`cardio:pubmed-39053958`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Evaluating the implementation of inclisiran in primary care: process evaluation interim findings from interviews with key stakeholders (`cardio:pubmed-40010816`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f210b64b104a092a0bea25f4d0a68dee4111dea6b5ce6510fb42b9f0626baf50
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
